$ALMU

Klamkin Jonathan sold $193K of ALMU

Klamkin Jonathan (Chief Executive Officer) sold 7,900 shares of Aeluma, Inc. (ALMU) at $24.39 ($0.19M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klamkin Jonathan
Published Jun 3, 2026, 9:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ALMU
Neutral
medium confidence
Mentioned
$ALMU
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ALMUNeutralLow
01

Why it matters

The disclosure may modestly influence short-term sentiment, but the 10b5-1 structure typically limits inference about near-term company outlook.

02

Market read

A single insider sale under a 10b5-1 plan—more of a sentiment datapoint than a catalyst.

03

What to watch

The article provides no context on total insider holdings changes beyond the post-transaction balance, nor any concurrent operational news; without that, signal-to-noise is low.

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-03; sale executed 2026-06-01 under a 10b5-1 plan.

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by the CEO with a stated pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ALMUNeutralMedium confidence
Context

CEO Jonathan Klamkin sold 7,900 shares in an open-market transaction disclosed via SEC Form 4 on ALMU.

Expected impact

Likely limited near-term price impact; any reaction should be small unless accompanied by unusual volume or other new fundamentals.

Evidence & confidence

The filing is a routine insider transaction under a Rule 10b5-1 plan, with no accompanying corporate event or guidance change in the article.

Market effects

No sector read-through; this is company-specific insider disclosure without broader industry catalyst.

None indicated.

None indicated.

Counterpoint

10b5-1 selling can be purely mechanical for liquidity/tax planning, so the market may overreact if it treats it as discretionary bearishness.

Key entities

  • Aeluma, Inc.

    Subject of the SEC Form 4 insider sale by CEO Jonathan Klamkin.

  • Jonathan Klamkin

    CEO and director who sold 7,900 shares of ALMU at $24.3851/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

High

Why is Aeluma stock surging today?

Aeluma stock rose 7.0% in pre-market trading after announcing a partnership with Sumitomo Chemical Advanced Technologies to develop and manufacture photonics wafers for AI datacom. The company is set to report Q4 and full-year 2026 earnings on September 16. The sole analyst's price target of $30.50 suggests significant upside from current levels.

$ALMUMed

The Speed of Light: 5 Stocks Powering AI’s Optical Future

MarketBeat highlights NVIDIA’s broader photonics investment and says the global photonics market is about $1.25T, growing mid-single digits through the next decade, with silicon photonics rising ~30% annually. It profiles Aeluma (NASDAQ: ALMU), citing quantum-dot lasers and a manufacturing method that grows optical-quality substrate on silicon. The article notes Aeluma is pre-revenue, seeks data-center/defense partnerships for design wins and prototype certifications, and targets production and

$ALMUMedAI 8/10

Aeluma Sees Accelerated Timeline for Quantum Commercialization

Aeluma (NASDAQ: ALMU) said the U.S. Department of Commerce announced proposed CHIPS Act incentives of more than $2 billion for nine companies to accelerate quantum computing, shifting from R&D to manufacturing. Aeluma supported one company that signed a letter of intent, with involvement contingent on a subcontract. Aeluma cited its scalable wafer platform and recent U.S. contracts for quantum materials and lasers.